Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients

Background: Convalescent plasma is the only antibody based therapy currently available for COVID-19 patients. It has robust historical precedence and sound biological plausibility. Although promising, convalescent plasma has not yet been shown to be safe as a treatment for COVID-19. Methods: Thus, w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:medRxiv
Autores principales: Joyner, Michael, Wright, R. Scott, Fairweather, DeLisa, Senefeld, Jonathon, Bruno, Katelyn, Klassen, Stephen, Carter, Rickey, Klompas, Allan, Wiggins, Chad, Shepherd, John RA, Rea, Robert, Whelan, Emily, Clayburn, Andrew, Spiegel, Matthew, Johnson, Patrick, Lesser, Elizabeth, Baker, Sarah, Larson, Kathryn, Ripoll Sanz, Juan, Andersen, Kylie, Hodge, David, Kunze, Katie, Buras, Matthew, Vogt, Matthew, Herasevich, Vitaly, Dennis, Joshua, Regimbal, Riley, Bauer, Philippe, Blair, Janis, van Buskirk, Camille, Winters, Jeffrey, Stubbs, James, Paneth, Nigel, Casadevall, Arturo
Formato: Artigo
Lenguaje:Inglês
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7274247/
https://ncbi.nlm.nih.gov/pubmed/32511566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.05.12.20099879
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares